Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Communication

<< Previous

Bullboard Posts

Next >>

Comment by CADInvestor12on Jul 17, 2024 5:46pm

111 Views

Post# 36137448

RE:RE:RE:RE:RE:RE:RE:RE:RE:Communication

VIVO was not included in Q1/23s results, you have to compare G&A expenses from Q1/24 & Q4/23 .. Q1/24 bad debt recovery + severance are ~$2M, adjust those out and you have G&A of ~$2.2M in Q1/24. Expecting gross margins to approach 40%, and hopeful that Q2 is where we see significant top & bottom line improvements

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario